Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-016846
Filing Date
2012-12-04
Accepted
2012-12-04 16:06:35
Documents
1
Period of Report
2012-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3568
  Complete submission text file 0001179110-12-016846.txt   4976
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Nielsen Ulrik B. (Reporting) CIK: 0001531962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 121240716